Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-06

Clinical Trial Update: Anakinra as a Treatment for Hydradenitis Suppurativa [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating anakinra for hidradenitis suppurativa has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • KINERET (ANAKINRA)

Snippet

Sponsor: University of California, San Francisco | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2014-08-06